$Cardiff Oncology (CRDF.US)$In a report released today, [Sha...
$Cardiff Oncology(CRDF.US$In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Cardiff Oncology (CRDF – Research Report), with a price target of $7.00. The company’s shares closed yesterday at $1.77.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment